GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Shiller PE Ratio

T2 Biosystems (FRA:3T2) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


T2 Biosystems Shiller PE Ratio Historical Data

The historical data trend for T2 Biosystems's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Shiller PE Ratio Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

T2 Biosystems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of T2 Biosystems's Shiller PE Ratio

For the Diagnostics & Research subindustry, T2 Biosystems's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Shiller PE Ratio falls into.



T2 Biosystems Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

T2 Biosystems's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, T2 Biosystems's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-2.447/131.7762*131.7762
=-2.447

Current CPI (Mar. 2024) = 131.7762.

T2 Biosystems Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -37.609 100.560 -49.284
201409 -55.096 100.428 -72.294
201412 -36.495 99.070 -48.543
201503 -48.972 99.621 -64.779
201506 -48.114 100.684 -62.972
201509 -50.787 100.392 -66.664
201512 -51.408 99.792 -67.884
201603 -49.390 100.470 -64.780
201606 -51.620 101.688 -66.894
201609 -45.441 101.861 -58.786
201612 -45.504 101.863 -58.867
201703 -44.880 102.862 -57.496
201706 -44.500 103.349 -56.740
201709 -37.755 104.136 -47.776
201712 -43.095 104.011 -54.599
201803 -29.196 105.290 -36.541
201806 -27.392 106.317 -33.951
201809 -21.425 106.507 -26.508
201812 -30.765 105.998 -38.247
201903 -30.090 107.251 -36.971
201906 -30.975 108.070 -37.770
201909 -28.148 108.329 -34.240
201912 -26.100 108.420 -31.723
202003 -19.910 108.902 -24.092
202006 -7.992 108.767 -9.683
202009 -6.792 109.815 -8.150
202012 -5.501 109.897 -6.596
202103 -5.880 111.754 -6.933
202106 -6.640 114.631 -7.633
202109 -7.157 115.734 -8.149
202112 -6.195 117.630 -6.940
202203 -441.288 121.301 -479.396
202206 -482.460 125.017 -508.546
202209 -297.597 125.227 -313.162
202212 -133.104 125.222 -140.071
202303 -123.073 127.348 -127.353
202306 -7.384 128.729 -7.559
202309 -3.233 129.860 -3.281
202312 -2.336 129.419 -2.379
202403 -2.447 131.776 -2.447

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


T2 Biosystems  (FRA:3T2) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


T2 Biosystems Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems (FRA:3T2) Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

T2 Biosystems (FRA:3T2) Headlines

No Headlines